Back | Next |
home / stock / lgnd / lgnd message board
Subject | By | Source | When |
---|---|---|---|
$LGNDZ is Roche | S-BEES-BUMBLEBEE | investorshub | 08/11/2022 9:53:10 AM |
Ligand Pharmaceuticals Provides Guidance | S-BEES-BUMBLEBEE | investorshub | 08/11/2022 9:45:39 AM |
Ligand Reports Second Quarter 2022 Financial Results | S-BEES-BUMBLEBEE | investorshub | 08/11/2022 9:27:56 AM |
H.C. Wainwright Sticks to Their Buy Rating for | S-BEES-BUMBLEBEE | investorshub | 08/11/2022 9:15:35 AM |
You're welcome, bud. | S-BEES-BUMBLEBEE | investorshub | 08/11/2022 12:45:46 AM |
TY Sir. $LGND | Mr Walnuts | investorshub | 08/11/2022 12:12:44 AM |
H.C. Wainwright analyst Joseph Pantginis reiterated a Buy | S-BEES-BUMBLEBEE | investorshub | 08/07/2022 3:15:48 PM |
Brilliant! And there's a good chance you're right | S-BEES-BUMBLEBEE | investorshub | 08/07/2022 3:14:03 PM |
I love game changerS, bro!! ;) $LGNDZ $LGNYZ | S-BEES-BUMBLEBEE | investorshub | 08/07/2022 3:11:57 PM |
The Ibox was completely erased. I've added a | S-BEES-BUMBLEBEE | investorshub | 08/07/2022 12:38:44 PM |
I can't even remember what goals we need | Stowe | investorshub | 06/06/2022 5:45:57 PM |
Several institutional owners bought $LGND's CVRs in the | S-BEES-BUMBLEBEE | investorshub | 06/06/2022 8:42:32 AM |
Did they buy any of the CVRs? | Stowe | investorshub | 05/26/2022 9:35:17 PM |
CEO + President & COO both acquired shares | S-BEES-BUMBLEBEE | investorshub | 05/26/2022 8:07:10 AM |
H.C. Wainwright analyst Joseph Pantginis reiterated a Buy | S-BEES-BUMBLEBEE | investorshub | 05/26/2022 8:04:47 AM |
Have you heard anything lately? | Stowe | investorshub | 05/20/2022 8:22:00 PM |
is this part of a CVR? | Stowe | investorshub | 04/29/2022 3:39:06 AM |
Ligand Pharmaceuticals Incorporated (NASDAQ:$LGND) will report first quarter | Stowe | investorshub | 04/29/2022 3:28:49 AM |
i have LGNDZ | Erz | investorshub | 04/04/2022 10:16:48 AM |
i have LGNDZ | Erz | investorshub | 04/04/2022 9:50:16 AM |
News, Short Squeeze, Breakout and More Instantly...
Ligand Pharmaceuticals Incorporated Company Name:
LGND Stock Symbol:
NASDAQ Market:
Conference Call Begins at 4:30 p.m. Eastern Time Today Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) today reported financial results for the three months ended March 31, 2024, and provided an operating forecast and business updates. Ligand management will host a conference cal...
Capital infusion will support botensilimab and balstilimab (BOT/BAL) clinical development, confirmatory Phase 3 trial, and launch readiness activities Ligand entitled to royalties and milestone payments on six Agenus-partnered programs as well as royalties on future global net sales gener...
Aterian Inc. (ATER) is expected to report for Q1 2024 Dorman Products Inc. (DORM) is expected to report $0.82 for Q1 2024 Hillman Solutions Corp. (HLMN) is expected to report $0.08 for Q1 2024 Wake Forest Bancshares, Inc. (WAKE) is expected to report for quarter end 2024-03-31 Inn...